circadian rhythm raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-07-11 and is reviewed periodically as new material appears.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
Between 1932 and 1933 Piłsudski and Beck initiated several incidents along the borders with Germany and Danzig, both to test whether Western powers would protect the Versailles arrangements (on which Polish security depended), and as preparation for a preventative war against Germany. At the same time they sent emissaries to London and Paris, looking for their support in stopping Germany's rearmament effort. An invasion to Danzig by Poland was scheduled for April 21, 1933, but the amassing of troops was discovered and the invasion was postponed. At the time an invasion by Poland would have posed a serious military threat to Germany, but with the British rejecting the idea (in favor of the Four-Power Pact), and with wavering support from the French, the Poles had eventually reneged on the idea of invasion. Between 1933 and 1934 Germany would increase its armament expenditures by 68%, and by January 1934 the two powers would sign a ten-year non-aggression pact. When Marshal Piłsudski died in 1935, he retained the support of dominant sections of Polish society even though he never risked testing his popularity in an honest election. His government was dictatorial, but at that time only Czechoslovakia remained democratic in all of the regions neighboring Poland. Historians have taken widely divergent views of the meaning and consequences of the coup Piłsudski perpetrated and his personal rule that followed.
== Economy == In 2024, the government reported that international sales of tequila from Tequila municipality reached approximately US $572 million. The majority of sales are to the United States, the top destination country in 2024.
The caffeine content of most Monster Energy drinks is approximately 10 mg/oz (33.81 mg / 100 mL), or 160 mg for a 16oz (473 mL) can. The packaging usually contains a warning label advising consumers against drinking more than 48oz per day (500 mL per day in Australia). The drinks are not recommended for children, pregnant or nursing women, or people sensitive to caffeine. The ingredients include carbonated water, sucrose, glucose, citric acid, natural flavors, taurine, sodium citrate, color added, panax ginseng root extract, L-carnitine L-tartrate, caffeine, sorbic acid, benzoic acid, niacinamide, sodium chloride, Glycine max glucuronolactone, inositol, guarana seed extract, pyridoxine hydrochloride, sucralose, riboflavin, maltodextrin, and cyanocobalamin.
=== Biotechnology === BASF was cooperating with Monsanto Company in research, development and marketing of biotechnology. In correlation to this work, BASF has licensed many gene editing tools including CRISPR Cas9 and CRISPR Cas12a (Cpf1). The BASF Plant Science subsidiary produces the Amflora and Starch Potato genetically modified potato with reduced amylose. In 2010 BASF conducted Department of Environment, Food and Rural Affairs approved trials of genetically modified potatoes in the United Kingdom. Starch Potato was authorised for use in the USA in 2014. Other GM crops are Phytaseed Canola varieties with phytase, sulfonylurea herbicide tolerant soybean and drought tolerant corn (with cold shock protein B) developed with Monsanto.
Sources: en.wikipedia.org
it is our view that Canada's proposal to legalize cannabis shares the objectives agreed to by member states in multilateral declarations", citing protection of vulnerable citizens, evidence-based policy, and public health, safety and welfare as "the heart of a balanced approach to treaty implementation." The CND and INCB stated, "this decision contravenes the provisions of the drug control conventions, and undermines the international legal drug control framework and respect for the rules-based international order." In Mexico, the Supreme Court in 2018 overturned as unconstitutional the prohibition of recreational cannabis use and ordered the government to enact corresponding legislation. In 2021, the Mexican Congress had still failed to change the laws, and the Court legalized personal use of cannabis. However, without updated legislation, the situation remains murky. Individuals have to apply for a permit and the federal criminal code with respect to recreational use has not been changed. The INCB, in its 2022 "Analysis of the world situation", reported, "In Mexico, legislative and policy changes concerning cannabis use for non-medical purposes continue to be in flux." In 2021, Malta legalized cannabis, the first EU country to do so. It adopted a law echoing article 2(9) of the Single Convention (exemption for the use of drugs for industrial purposes), leading some scholars to consider it the first national legalization to achieve compliance with the drug control treaties.
Liquid Scintillation Counting, University of Wisconsin–Milwaukee Radiation Safety Program Principles and Applications of Liquid Scintillation Counting, National Diagnostics K. Regan, "Cerenkov counting technique for beta particles: advantages and limitations". J. Chem. Educ., August 1983, 60 (8), 682–684. doi:10.1021/ed060p682
== Contraindications == Dihydroergotamine is contraindicated with potent CYP3A4 inhibitors, like macrolide antibiotics. Contraindications for dihydroergotamine include: pregnancy, kidney failure or liver failure, coronary, cerebral, and peripheral vascular disease, hypersensitivity reactions, sepsis, and uncontrolled hypertension.
14 March Members of the NASUWT narrowly vote to accept a pay offer, ending the prospect of further strike action in schools in Scotland. BBC Scotland hosts the final televised debate of the SNP leadership election. 16 March – Scientists identify a gene variant that is known to increases the risk of breast and ovarian cancer, and trace it to people with Orkney Island heritage, more specifically those with ancestry on the island of Westray. 18 March – Peter Murrell resigns as chief executive of the Scottish National Party amid a row over party membership. Mike Russell succeeds him as interim chief executive. 21 March – At 8pm, Times Radio airs a leadership debate from Edinburgh and featuring the three candidates in the Scottish National Party leadership election. 22 March First Minister Nicola Sturgeon issues a "sincere, heartfelt and unreserved" apology to people affected by the practice of forced adoption in Scotland during the 1950s, 1960s and 1970s. A major incident is declared, with 35 injuries reported, after the 76m-long RV Petrel research vessel tips over at a dock in Leith. 23 March Nicola Sturgeon attends her final First Minister's Questions as First Minister of Scotland. The TikTok app is banned on all Scottish Government phones and electronic devices. 24 March – Research led by the University of Edinburgh suggests one in 50 people in Scotland have had lasting ill-effects after contracting COVID-19. 25 March – HIV Scotland announces it will close due to issues with governance and financials.
== P == Pacinian corpuscle A type of rapidly adapting mechanoreceptor located deep in the skin, responsible for detecting vibration and pressure. Pain An unpleasant sensory and emotional experience associated with actual or potential tissue damage. In neuroscience, pain is studied through nociception, pain pathways, and perception. Paralysis The loss of voluntary muscle function, often caused by damage to the brain, spinal cord, or peripheral nerves. Paraneoplastic syndrome A rare disorder triggered by an immune response to cancer that affects the nervous system. Can lead to sensory, motor, or cognitive symptoms. Parietal lobe A region of the cerebral cortex located near the top and back of the brain, involved in processing somatosensory information, spatial orientation, and body awareness. Parkinson’s disease A neurodegenerative disorder characterized by tremors, rigidity, bradykinesia, and postural instability. Caused by loss of dopaminergic neurons in the substantia nigra. Parvocellular pathway A visual processing stream originating in small ganglion cells of the retina, responsible for high-acuity and color vision. Projects to the lateral geniculate nucleus. Periaqueductal gray (PAG) A midbrain region involved in pain modulation, defensive behavior, and autonomic regulation. Contains opioid receptors and descending pain control pathways. Peripheral nervous system (PNS) All nerves and ganglia outside the brain and spinal cord. It includes sensory and motor neurons as well as autonomic nerves. Periventricular Located near or surrounding the brain’s ventricular system.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.